PGNY Progyny Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PGNY

Price (delayed)

$49.88

Market cap

$4.35B

P/E Ratio

92.37

Dividend/share

N/A

EPS

$0.54

Enterprise value

$4.29B

Sector: Healthcare
Industry: Health Information Services

Highlights

Progyny's gross profit has surged by 54% YoY and by 15% QoQ
The revenue has surged by 50% year-on-year and by 11% since the previous quarter
PGNY's quick ratio is down by 32% year-on-year and by 3.6% since the previous quarter

Key stats

What are the main financial stats of PGNY
Market
Shares outstanding
87.22M
Market cap
$4.35B
Enterprise value
$4.29B
Valuations
Price to earnings (P/E)
92.37
Price to book (P/B)
25.88
Price to sales (P/S)
12.4
EV/EBIT
501.09
EV/EBITDA
409.82
EV/Sales
12.44
Earnings
Revenue
$344.86M
EBIT
$8.56M
EBITDA
$10.46M
Free cash flow
$35.17M
Per share
EPS
$0.54
Free cash flow per share
$0.41
Book value per share
$1.93
Revenue per share
$4.02
TBVPS
$2.81
Balance sheet
Total assets
$253.93M
Total liabilities
$86.98M
Debt
$8.32M
Equity
$166.95M
Working capital
$112.44M
Liquidity
Debt to equity
0.05
Current ratio
2.45
Quick ratio
2.38
Net debt/EBITDA
-5.92
Margins
EBITDA margin
3%
Gross margin
20.3%
Net margin
13.5%
Operating margin
2.4%
Efficiency
Return on assets
22.8%
Return on equity
34.7%
Return on invested capital
14.6%
Return on capital employed
4.9%
Return on sales
2.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PGNY stock price

How has the Progyny stock price performed over time
Intraday
-5.83%
1 week
4.5%
1 month
5.83%
1 year
116.96%
YTD
17.67%
QTD
12.06%

Financial performance

How have Progyny's revenue and profit performed over time
Revenue
$344.86M
Gross profit
$70.06M
Operating income
$8.35M
Net income
$46.46M
Gross margin
20.3%
Net margin
13.5%
Progyny's gross profit has surged by 54% YoY and by 15% QoQ
The revenue has surged by 50% year-on-year and by 11% since the previous quarter
PGNY's operating margin is down by 43% year-on-year and by 14% since the previous quarter
Progyny's operating income has decreased by 14% YoY and by 2.3% QoQ

Growth

What is Progyny's growth rate over time

Valuation

What is Progyny stock price valuation
P/E
92.37
P/B
25.88
P/S
12.4
EV/EBIT
501.09
EV/EBITDA
409.82
EV/Sales
12.44
The EPS has grown by 42% since the previous quarter
PGNY's equity is up by 46% year-on-year and by 31% since the previous quarter
PGNY's price to book (P/B) is 46% higher than its last 4 quarters average of 18.8
PGNY's price to sales (P/S) is 57% higher than its last 4 quarters average of 8.4
The revenue has surged by 50% year-on-year and by 11% since the previous quarter

Efficiency

How efficient is Progyny business performance
The return on sales has surged by 168% year-on-year and by 150% since the previous quarter
The company's return on equity has surged by 139% YoY
PGNY's return on invested capital has surged by 113% year-on-year and by 87% since the previous quarter

Dividends

What is PGNY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PGNY.

Financial health

How did Progyny financials performed over time
PGNY's total assets is 192% more than its total liabilities
PGNY's total liabilities has surged by 141% year-on-year and by 16% since the previous quarter
PGNY's total assets has soared by 69% YoY and by 26% from the previous quarter
The company's debt is 95% lower than its equity
PGNY's equity is up by 46% year-on-year and by 31% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.